Skip to content
Stem cell section cover: a glowing stem cell cluster on a black background

Dementia: what Cheongdam Cell Clinic says about stem cells

Dementia among the 'difficult to cure diseases' the clinic groups together

Quick answer

Cheongdam Cell Clinic lists dementia among the 'difficult to cure diseases' its 淸(Rejuvenation)CELL programme is mentioned alongside, based on the rationale of whole-body immune and vascular regeneration. Dementia, however, has multiple causes such as Alzheimer's disease or vascular dementia, and diagnosis and care require a neurologist or geriatric psychiatrist. Human stem-cell research for dementia remains largely investigational worldwide, with no standard treatment guideline recognising it as primary care.

Key facts

Related programme
淸(Rejuvenation)CELL
Most common cause
Alzheimer's disease
Specialist to consult
Neurologist or geriatric psychiatrist
Stem-cell evidence
Mostly still investigational
Caution
Early diagnosis matters more than supplementary programmes

Dementia is one of the terms listed under 'difficult to cure diseases' on Cheongdam Cell Clinic's 淸(Rejuvenation)CELL programme page, alongside stroke, atopy, psoriasis, rheumatoid arthritis and autoimmune disease. The clinic does not describe a mechanism specific to dementia, instead folding it into the broader framework of whole-body cell and immune regeneration.

Dementia has multiple causes, the most common being Alzheimer's disease, followed by vascular dementia and other types such as Lewy body dementia. Each has different disease mechanisms and care approaches. Accurate diagnosis requires neuropsychological assessment, brain imaging and detailed history-taking by a specialist.

Stem-cell research for Alzheimer's disease and other dementias is underway in multiple countries, exploring potential to reduce brain inflammation and possibly slow neuronal decline. However, most of this work remains at early-to-mid-stage clinical trials, and no major global drug regulator has approved it as standard treatment.

Cheongdam Cell Clinic's website does not indicate a dedicated neurology department, geriatric psychiatry service, or memory clinic. The 淸(Rejuvenation)CELL programme is a whole-body intravenous stem-cell injection for anti-ageing and general immune support, not a specialised diagnostic or treatment programme for dementia.

Families noticing unusual forgetfulness, confusion about time or place, or personality changes in an older relative should first seek evaluation from a neurologist or geriatric psychiatrist. Early diagnosis affects care planning and access to evidence-based disease-modifying medications, such as cholinesterase inhibitors.

If an older adult with early-stage, stable dementia is interested in the 淸(Rejuvenation)CELL programme for general health support, a caregiver or family member should coordinate closely with the clinic, disclose full treatment and medication history, and always consult the patient's treating neurologist before deciding.

In summary, the mention of dementia on Cheongdam Cell Clinic's website should be understood as part of a broad marketing framework, not a specialised treatment with clear supporting evidence. Caregivers should always prioritise diagnosis and standard treatment from specialist physicians first.

Frequently asked questions

  • Can stem cells cure Alzheimer's disease?

    No confirmed evidence exists for a cure; most research remains at the clinical-trial stage.

  • Does Cheongdam Cell Clinic have a dedicated memory clinic?

    The clinic's website does not indicate a dedicated neurology department or memory clinic.

  • What should be done first if an older adult starts showing forgetfulness?

    Seek evaluation from a neurologist or geriatric psychiatrist for detailed diagnosis first.

  • How many types of dementia are there?

    There are several types, such as Alzheimer's, vascular dementia and Lewy body dementia, each requiring different care.

  • Can this programme replace Alzheimer's medication?

    No, evidence-based medication such as cholinesterase inhibitors should continue as prescribed.

Medical cautions

5 points • reviewed 2026-08-28

Expand
  • This article is educational information only — not a diagnosis, prescription, or personal medical advice.
  • Outcomes vary by person, depending on age, underlying conditions, current medication, and the treating doctor's technique.
  • Consult a licensed physician and verify the clinic's licence before deciding on any treatment.
  • Some treatments (certain stem cell therapies in particular) are regulated differently by country — check Thai and Korean rules before travelling.
  • Prices, packages, and service details can change — confirm directly with the provider before paying.

Reviewed and last updated: 2026-08-28

References and sources

4 sources • every claim is traceable

Expand
  1. 1. Korea Ministry of Food and Drug Safety (MFDS)

    https://www.mfds.go.kr/eng/index.do

  2. 2. Korea Ministry of Health and Welfare (MOHW)

    https://www.mohw.go.kr/eng/

  3. 3. PubMed medical research database (NIH)

    https://pubmed.ncbi.nlm.nih.gov/

  4. 4. Medical Korea — official info for international patients (KHIDI)

    https://www.medicalkorea.or.kr/

Browse the full reference library →

Share this page

Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.

Back to categories
See all articles
See all in this category